RU2018137036A - Комбинированная вакцина против инфекции вирусами pcv2 и prrs, содержащая альбумин - Google Patents
Комбинированная вакцина против инфекции вирусами pcv2 и prrs, содержащая альбумин Download PDFInfo
- Publication number
- RU2018137036A RU2018137036A RU2018137036A RU2018137036A RU2018137036A RU 2018137036 A RU2018137036 A RU 2018137036A RU 2018137036 A RU2018137036 A RU 2018137036A RU 2018137036 A RU2018137036 A RU 2018137036A RU 2018137036 A RU2018137036 A RU 2018137036A
- Authority
- RU
- Russia
- Prior art keywords
- vaccine
- pcv2
- immunogen
- prrs virus
- replicating
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title claims 20
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 title claims 12
- 241000700605 Viruses Species 0.000 title claims 10
- 108010088751 Albumins Proteins 0.000 title claims 7
- 102000009027 Albumins Human genes 0.000 title claims 7
- 208000015181 infectious disease Diseases 0.000 title claims 5
- 241001673669 Porcine circovirus 2 Species 0.000 title 1
- 230000002163 immunogen Effects 0.000 claims 11
- 230000002238 attenuated effect Effects 0.000 claims 7
- 230000003362 replicative effect Effects 0.000 claims 7
- 241001533384 Circovirus Species 0.000 claims 5
- 238000011321 prophylaxis Methods 0.000 claims 3
- 230000009385 viral infection Effects 0.000 claims 2
- 241000204045 Mycoplasma hyopneumoniae Species 0.000 claims 1
- 108010058846 Ovalbumin Proteins 0.000 claims 1
- 101710159752 Poly(3-hydroxyalkanoate) polymerase subunit PhaE Proteins 0.000 claims 1
- 101100382437 Porcine circovirus 2 Cap gene Proteins 0.000 claims 1
- 101710130262 Probable Vpr-like protein Proteins 0.000 claims 1
- 210000004207 dermis Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 229940092253 ovalbumin Drugs 0.000 claims 1
- 241000701447 unidentified baculovirus Species 0.000 claims 1
- 238000002255 vaccination Methods 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16161982.0 | 2016-03-23 | ||
| EP16161982 | 2016-03-23 | ||
| PCT/EP2017/056801 WO2017162727A1 (en) | 2016-03-23 | 2017-03-22 | A combination vaccine against pcv2 and prrs virus infection comprising albumin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2018137036A true RU2018137036A (ru) | 2020-04-23 |
| RU2018137036A3 RU2018137036A3 (cg-RX-API-DMAC10.html) | 2020-06-04 |
Family
ID=55589749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018137036A RU2018137036A (ru) | 2016-03-23 | 2017-03-22 | Комбинированная вакцина против инфекции вирусами pcv2 и prrs, содержащая альбумин |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10953084B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3432921A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2019509302A (cg-RX-API-DMAC10.html) |
| CN (1) | CN108778325A (cg-RX-API-DMAC10.html) |
| BR (1) | BR112018069193A2 (cg-RX-API-DMAC10.html) |
| RU (1) | RU2018137036A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2017162727A1 (cg-RX-API-DMAC10.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2844168C1 (ru) * | 2020-10-29 | 2025-07-28 | Интервет Интернэшнл Б.В. | Комбинированная вакцина для защиты свиней от различных заболеваний |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2275132T3 (da) | 2005-12-29 | 2021-05-17 | Boehringer Ingelheim Animal Health Usa Inc | Multivalente pcv2-immunogeniske sammensætninger og fremgangsmåder til at fremstille dem |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2587321A1 (en) | 2005-01-13 | 2006-07-20 | Boehringer Ingelheim Vetmedica Gmbh | Improved prrs vaccines |
| CN101277717A (zh) | 2005-09-09 | 2008-10-01 | 英特威国际有限公司 | Pcv-2疫苗 |
| CA2635430A1 (en) | 2005-12-29 | 2007-08-23 | Boehringer Ingelheim Vetmedica, Inc. | Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs |
| PT2094872T (pt) | 2006-12-15 | 2017-04-27 | Boehringer Ingelheim Vetmedica Inc | Tratamento de porcos seropositivos para o anticorpo anti-pcv2 com antigénio de pcv2 |
| US8728487B2 (en) | 2011-01-20 | 2014-05-20 | Hua Wu | Attenuated live vaccine for prevention of porcine reproductive and respiratory syndrome |
| US9120859B2 (en) * | 2012-04-04 | 2015-09-01 | Zoetis Services Llc | Mycoplasma hyopneumoniae vaccine |
| US9457073B2 (en) | 2012-09-26 | 2016-10-04 | University Of Manitoba | Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity |
| CN105246505A (zh) * | 2013-04-30 | 2016-01-13 | 勃林格殷格翰动物保健公司 | PCV2a亚型(PCV2a)的ORF2蛋白用于交叉保护中的用途 |
| TWI670085B (zh) * | 2014-02-19 | 2019-09-01 | 荷蘭商英特威國際公司 | 液體穩定之豬病毒疫苗 |
| CN104056265B (zh) * | 2014-07-11 | 2016-04-27 | 江苏南农高科技股份有限公司 | 猪圆环病毒2型、猪繁殖与呼吸综合征二联疫苗及其制备方法 |
-
2017
- 2017-03-22 RU RU2018137036A patent/RU2018137036A/ru not_active Application Discontinuation
- 2017-03-22 JP JP2018549454A patent/JP2019509302A/ja not_active Withdrawn
- 2017-03-22 EP EP17711679.5A patent/EP3432921A1/en active Pending
- 2017-03-22 US US16/086,629 patent/US10953084B2/en active Active
- 2017-03-22 BR BR112018069193A patent/BR112018069193A2/pt not_active IP Right Cessation
- 2017-03-22 CN CN201780017516.9A patent/CN108778325A/zh active Pending
- 2017-03-22 WO PCT/EP2017/056801 patent/WO2017162727A1/en not_active Ceased
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2844168C1 (ru) * | 2020-10-29 | 2025-07-28 | Интервет Интернэшнл Б.В. | Комбинированная вакцина для защиты свиней от различных заболеваний |
Also Published As
| Publication number | Publication date |
|---|---|
| RU2018137036A3 (cg-RX-API-DMAC10.html) | 2020-06-04 |
| US20190091321A1 (en) | 2019-03-28 |
| BR112018069193A2 (pt) | 2019-01-29 |
| CN108778325A (zh) | 2018-11-09 |
| WO2017162727A1 (en) | 2017-09-28 |
| US10953084B2 (en) | 2021-03-23 |
| EP3432921A1 (en) | 2019-01-30 |
| JP2019509302A (ja) | 2019-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SA521430813B1 (ar) | لقاح وحدات فرعية لعلاج عدوى الجهاز التنفسي أو الوقاية منها | |
| PH12019500289A1 (en) | Vaccines directed against a human enteroviruses | |
| EP4218813A3 (en) | High concentration anti-c5 antibody formulations | |
| PH12021550479A1 (en) | Dengue vaccine unit dose and administration thereof | |
| RU2018137034A (ru) | Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae | |
| JOP20220349A1 (ar) | توليفة لقاح ضد الإصابة بفيروس مخلوي تنفسي | |
| JP2019509300A5 (cg-RX-API-DMAC10.html) | ||
| WO2017214596A8 (en) | Compositions and methods for preventing and treating zika virus infection | |
| MD20210028A2 (ro) | Compoziţie de vaccin combinat, care conţine o doză redusă de poliovirus inactivat, şi procedeu de preparare a acesteia | |
| EA201690057A1 (ru) | Остеопонтин молока млекопитающих для повышения иммунологической реактивности | |
| MX2022003090A (es) | Vacuna combinada para ser administrable intradermicamente. | |
| BR112016012435A8 (pt) | vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2 | |
| RU2019136252A (ru) | Вакцины, содержащие патогены свиней, для ассоциированного несмешанного применения | |
| RU2018137033A (ru) | Вакцина для внутрикожного применения против инфекции вируса pcv2 и prrs | |
| RU2524430C1 (ru) | Вакцина для профилактики сибирской язвы и некробактериоза животных и способ получения ее | |
| JP2019509302A5 (cg-RX-API-DMAC10.html) | ||
| JP2019512518A5 (cg-RX-API-DMAC10.html) | ||
| CN106237328A (zh) | 一种用于治疗小鹅瘟的生物制品及其制备方法 | |
| JP2016514114A5 (cg-RX-API-DMAC10.html) | ||
| MX2023009192A (es) | Vacuna para mycoplasma bovis. | |
| RU2016114713A (ru) | Способы и композиции для лечения s. equi инфекции | |
| RU2025135206A (ru) | Комбинированная вакцина против erysipelothrix rhusiopathiae, парвовируса свиней и бактерии leptospra | |
| RU2025135193A (ru) | Вакцина против erysipelothrix rhusiopathiae и парвовируса свиней | |
| RU2022116197A (ru) | Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae | |
| TH1801005741A (th) | วัคซีนสำหรับการประยุกต์ใช้ภายในผิวหนังเพื่อต่อต้านการติดเชื้อไวรัสpcv2และprrs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20201109 |